These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33360004)

  • 41. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics.
    Hong M; Fan S; Yu Z; Gao C; Fang Z; Du L; Wang S; Chen X; Xu M; Zhou C
    J Magn Reson Imaging; 2023 Aug; 58(2):454-463. PubMed ID: 36440711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
    Kondo T; Hayashi N; Ohde S; Suzuki K; Yoshida A; Yagata H; Niikura N; Iwamoto T; Kida K; Murai M; Takahashi Y; Tsunoda H; Nakamura S; Yamauchi H
    J Surg Oncol; 2015 Oct; 112(5):476-80. PubMed ID: 26346047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
    Shigematsu H; Kadoya T; Masumoto N; Matsuura K; Emi A; Kajitani K; Amioka A; Okada M
    Clin Breast Cancer; 2014 Oct; 14(5):358-64. PubMed ID: 24962555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
    Shin HJ; Choi WJ; Park SY; Ahn SH; Son BH; Chung IY; Lee JW; Ko BS; Kim JS; Chae EY; Cha JH; Kim HH
    Clin Breast Cancer; 2022 Apr; 22(3):e374-e386. PubMed ID: 34776365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
    Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
    Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
    Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
    Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
    van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is ductal carcinoma in situ with "possible invasion" more predictive of invasive carcinoma than pure ductal carcinoma in situ?
    Arazi-Kleinman T; Causer PA; Nofech-Mozes S; Jong RA
    Can Assoc Radiol J; 2012 May; 63(2):146-52. PubMed ID: 21561735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
    Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
    Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
    Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
    J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
    Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
    Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
    Park AY; Gweon HM; Son EJ; Yoo M; Kim JA; Youk JH
    Eur J Radiol; 2014 Apr; 83(4):654-9. PubMed ID: 24534119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy.
    Chan MY; Lim S
    Asian J Surg; 2010 Apr; 33(2):76-82. PubMed ID: 21029943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature.
    Dória MT; Maesaka JY; Soares de Azevedo Neto R; de Barros N; Baracat EC; Filassi JR
    Clin Breast Cancer; 2018 Oct; 18(5):e805-e812. PubMed ID: 29798815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
    Prendeville S; Ryan C; Feeley L; O'Connell F; Browne TJ; O'Sullivan MJ; Bennett MW
    Breast; 2015 Jun; 24(3):197-200. PubMed ID: 25681861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
    Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
    J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
    Catteau X; Simon P; Noël JC
    Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.